Alterations of protein mono-ADP-ribosylation and diabetic neuropathy: a novel pharmacological approach

Author： Gorio A.   Donadoni M.L.   Finco C.   Borella F.   Di Giulio A.M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.311, Iss.1, 1996-09, pp. : 21-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Update on the Pharmacological Management of Post-Herpetic Neuralgia and Painful Diabetic Neuropathy

By Zin Che S.  

CNS Drugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 417-442

Adis International

Access to resources Recommend Favorite

Antinociceptive effect of the novel compound OT-7100 in a diabetic neuropathy model

By Miki S.   Yoshinaga N.   Iwamoto T.   Yasuda T.   Sato S.  

European Journal of Pharmacology, Vol. 430, Iss. 2, 2001-11 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite

Poly(ADP-ribosylation) and Neoplastic Transformation: Effect of PARP Inhibitors

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 5, 2013-06 ,pp. : 524-536

Bentham Science Publishers

Access to resources Recommend Favorite

Duloxetine in diabetic neuropathy

By Smith Timothy R  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 215-223

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for diabetic neuropathy

By Tahrani Abd A   Askwith Trevor   Stevens Martin J  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 661-683

Informa Healthcare

Access to resources Recommend Favorite